Compile Data Set for Download or QSAR
Report error Found 230 Enz. Inhib. hit(s) with all data for entry = 5968
TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103214(US8541407, 191)
Affinity DataIC50: 48nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103070(US8541407, 47)
Affinity DataIC50: 53nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103082(US8541407, 59)
Affinity DataIC50: 70nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103216(US8541407, 193)
Affinity DataIC50: 73nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103083(US8541407, 60)
Affinity DataIC50: 76nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103047(US8541407, 24)
Affinity DataIC50: 83nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103086(US8541407, 63)
Affinity DataIC50: 84nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103251(US8541407, 228)
Affinity DataIC50: 96nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103149(US8541407, 126)
Affinity DataIC50: 99nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103053(US8541407, 30)
Affinity DataIC50: 100nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103074(US8541407, 51)
Affinity DataIC50: 110nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103079(US8541407, 56)
Affinity DataIC50: 110nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103121(US8541407, 98)
Affinity DataIC50: 110nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103138(US8541407, 115)
Affinity DataIC50: 110nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103141(US8541407, 118)
Affinity DataIC50: 110nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103071(US8541407, 48)
Affinity DataIC50: 120nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103127(US8541407, 104)
Affinity DataIC50: 120nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103133(US8541407, 110)
Affinity DataIC50: 120nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103140(US8541407, 117)
Affinity DataIC50: 120nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103073(US8541407, 50)
Affinity DataIC50: 130nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103146(US8541407, 123)
Affinity DataIC50: 130nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103242(US8541407, 219)
Affinity DataIC50: 130nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103061(US8541407, 38)
Affinity DataIC50: 140nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103124(US8541407, 101)
Affinity DataIC50: 140nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103137(US8541407, 114)
Affinity DataIC50: 140nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103143(US8541407, 120)
Affinity DataIC50: 140nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103245(US8541407, 222)
Affinity DataIC50: 140nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103060(US8541407, 37)
Affinity DataIC50: 150nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103139(US8541407, 116)
Affinity DataIC50: 150nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103226(US8541407, 203)
Affinity DataIC50: 150nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103050(US8541407, 27)
Affinity DataIC50: 160nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103054(US8541407, 31)
Affinity DataIC50: 160nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103078(US8541407, 55)
Affinity DataIC50: 160nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103135(US8541407, 112)
Affinity DataIC50: 170nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103154(US8541407, 131)
Affinity DataIC50: 170nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103119(US8541407, 96)
Affinity DataIC50: 200nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103122(US8541407, 99)
Affinity DataIC50: 200nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103225(US8541407, 202)
Affinity DataIC50: 210nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103128(US8541407, 105)
Affinity DataIC50: 220nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103142(US8541407, 119)
Affinity DataIC50: 220nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103067(US8541407, 44)
Affinity DataIC50: 230nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103072(US8541407, 49)
Affinity DataIC50: 240nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103126(US8541407, 103)
Affinity DataIC50: 240nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103229(US8541407, 206)
Affinity DataIC50: 240nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103152(US8541407, 129)
Affinity DataIC50: 250nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103063(US8541407, 40)
Affinity DataIC50: 260nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103218(US8541407, 195)
Affinity DataIC50: 280nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103118(US8541407, 95)
Affinity DataIC50: 300nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103144(US8541407, 121)
Affinity DataIC50: 310nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

TargetRAC-alpha serine/threonine-protein kinase(Human)
Arqule

US Patent
LigandPNGBDBM103188(US8541407, 165)
Affinity DataIC50: 330nMAssay Description:Biochemical assay using Akt AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay) technology.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/3/2013
Entry Details
Go to US Patent

Displayed 1 to 50 (of 230 total ) | Next | Last >>
Jump to: